Samsung Biologics opens development base in San Francisco
Samsung Biologics CEO Kim Tae-han speaks during an online press conference on the company's new R&D center in San Francisco, Thursday. Courtesy of Samsung BiologicsDrugmaker to expand network in Eastern U.S., Europe, China By Nam Hyun-woo Samsung Biologics has opened its first overseas base in San Francisco as part of the contract development and manufacturing organization's efforts to provide seamless services to more than 2,500 life science and biotechnology firms in the city.Also at the conference, the company said it will set up additional R&D centers in Boston, Europe and China in the coming years, as part of its bid to provide better services to clients regardless of their location. “With the opening of the San Francisco R&D center, we will be able to provide services as a local partner to our global biotech clients and help them to improve competitiveness in drug development,” Samsung Biologics CEO Kim Tae-han said during an online press conference, Thursday.“We plan to continue our expansion into Boston, Europe and China. In 2020 and beyond, our
Oct 29, 2020By Nam Hyun-woo